Nucala 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FYX26
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,715
Award facts
- Contract value 100% obligated
- $22,714.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,714.80 to DMS Pharmaceutical Group Inc. for the supply of Nucala 100 mg/ml syringes. The award was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a firm fixed-price contract with no set-aside designation. Performance will take place at the vendor's location in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has established itself as a critical supplier within the federal pharmaceutical supply chain. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. Nucala, a biologic injection used primarily for severe asthma and eosinophilic conditions, represents one of many specialty pharmaceutical products the vendor supplies to support the medical needs of military personnel and beneficiaries. The company's extensive federal contract portfolio and established relationship with the DLA through the SPE2DB program demonstrate its capability to deliver specialized pharmaceutical products on accelerated timelines to meet operational requirements.
Quick answers
Who was awarded contract SPE2DB25FYX26?
SPE2DB25FYX26 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FYX26 worth?
The government has obligated $22,715 on SPE2DB25FYX26.
Is contract SPE2DB25FYX26 an order under another contract?
Yes. SPE2DB25FYX26 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX26 competed?
The extent of competition for SPE2DB25FYX26 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award